Hyoscyamine
Hyoscyamine is an anticholinergic (antispasmodic) medicine used as add-on treatment for stomach and bowel conditions such as peptic ulcer and irritable bowel syndrome, bladder spasm problems, and certain other uses depending on the product.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 56 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Hyoscyamine is an older antispasmodic, on the U.S. market since the 1950s and available generically, that blocks acetylcholine (a nerve signal) to relax gut and bladder spasms and slow secretions. It is mostly used as an add-on for irritable bowel syndrome, peptic ulcer or bladder spasm. Most people manage it, but the drying effects show up: dry mouth, blurred vision, constipation and some drowsiness. Watch for overheating, since it cuts sweating and heat stroke is a real risk in hot weather, and call your prescriber about new confusion or agitation. It is not safe with glaucoma, myasthenia gravis, or a blockage of the bladder outlet or bowel.
Clinical pearls
- If you also use antacids, take hyoscyamine before meals and the antacid after, because antacids reduce how much hyoscyamine you absorb.
- Tricyclic antidepressants, amantadine, haloperidol, MAO inhibitors and some antihistamines all add to its drying and sedating effects.
- Older adults feel it more strongly, so watch closely for dizziness, confusion or trouble urinating.
- With an ileostomy or colostomy, new diarrhea can be an early sign of a partial bowel blockage, so report it.
Patient information guide A plain-language walkthrough of Hyoscyamine, written from its FDA label.
What Hyoscyamine is used for
▾
Hyoscyamine is used as add-on treatment for many stomach, bowel and bladder problems. Uses vary by product.
- Peptic ulcer (add-on therapy)
- Irritable bowel syndrome and other functional gastrointestinal disorders
- Spastic colitis, spastic bladder, cystitis, pylorospasm and abdominal cramps
- Mild dysenteries, diverticulitis and acute enterocolitis
- Neurogenic bladder and neurogenic bowel disturbances
- Biliary and renal colic, along with morphine or other narcotics or analgesics
- Acute rhinitis, as a “drying agent”
- Parkinsonism, to reduce rigidity, tremors, drooling and excess sweating (several tablet products)
- Poisoning by anticholinesterase agents (several products, including the injection)
- Infant colic (elixir and drops, including Hyosyne and Levsin)
- Hyoscyamine Sulfate Injection: reducing gut motility for endoscopy, pain in pancreatitis, certain cases of partial heart block, and use before anesthesia
How Hyoscyamine works
▾
Hyoscyamine blocks the action of acetylcholine, a chemical messenger, at nerve receptors in smooth muscle, the heart and glands. This slows gut movement, lowers stomach acid and reduces secretions, which helps ease spasm and cramping.
Hyoscyamine dosage
▾
How it is taken depends on the product. Many tablet labels call for dosing 30 to 60 minutes before meals and at bedtime, repeated every few hours as needed, with a daily limit. Dissolving, chewable and under-the-tongue tablets can be taken with or without water.
- Oral drops need careful measuring, and dosing for young children is by weight.
- The injection is given by a healthcare professional.
- Extended-release tablets release the drug over 12 hours.
Follow your prescriber and product label.
Dosing details from the FDA-approved label
From the Hyoscyamine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Oral drops (solution): adults and pediatric patients 12 years of age and older
- 1 to 2 mL every four hours or as needed
- Maximum: Do not exceed 12 mL in 24 hours
- Dosage may be adjusted according to the conditions and severity of symptoms; measure dosage very carefully
- Oral drops (solution): pediatric patients 2 to under 12 years of age
- 1/4 to 1 mL every four hours or as needed
- Maximum: Do not exceed 6 mL in 24 hours
- Measure dosage very carefully
- Oral drops (solution): pediatric patients under 2 years of age
- Based on body weight, may be repeated every four hours or as needed: 3.4 kg (7.5 lb.) 4 drops
- 5 kg (11 lb.) 5 drops
- 7 kg (15 lb.) 6 drops
- 10 kg (22 lb.) 8 drops
- Maximum: In 24 hours: 24 drops (3.4 kg); 30 drops (5 kg); 36 drops (7 kg); 48 drops (10 kg)
- Dose based on body weight; use a dropper marked 3, 4, 5 DROPS and 0.25 mL
- Elixir: adults and pediatric patients 12 years of age and older
- 1 to 2 teaspoonfuls every four hours or as needed
- Maximum: Do not exceed 12 teaspoonfuls in 24 hours
- Measure dosage very carefully
- Elixir: pediatric patients 2 to under 12 years of age
- Based on body weight, may be repeated every four hours or as needed: 10 kg (22 lb.) 1/4 teaspoon (1.25 mL)
- 20 kg (44 lb.) 1/2 teaspoonful (2.5 mL)
- 40 kg (88 lb.) 3/4 teaspoonful (3.75 mL)
- 50 kg (110 lb.) 1 teaspoonful (5 mL)
- Maximum: Do not exceed 6 teaspoonfuls in 24 hours
- Dose based on body weight
- Tablets (oral, sublingual, orally disintegrating, chewable) 0.125 mg: adults and pediatric patients 12 years of age and older
- 1 to 2 tablets every four hours or as needed
- Maximum: Do not exceed 12 tablets in 24 hours
- Some labels: take 30 to 60 minutes before meals and at bedtime; geriatric patients may be more sensitive to the usual adult dose
- Tablets (oral, sublingual, orally disintegrating, chewable) 0.125 mg: pediatric patients 2 to under 12 years of age
- 1/2 to 1 tablet every four hours or as needed
- Maximum: Do not exceed 6 tablets in 24 hours
- Injection: gastrointestinal disorders (adults)
- 0.5 to 1 mL (0.25 to 0.5 mg) subcutaneously, intramuscularly, or intravenously
- Some patients need a single dose, others two, three, or four times a day at four hour intervals
- Injection: diagnostic procedures (adults)
- 0.5 to 1 mL (0.25 to 0.5 mg) administered intravenously 5 to 10 minutes prior to the diagnostic procedure
- Injection: anesthesia, adults and pediatric patients over 2 years of age
- Pre-anesthetic: 5 µg (0.005 mg) per kg of body weight, given thirty to sixty minutes prior to induction of anesthesia
- During surgery for drug-induced bradycardia, intravenously in increments of 0.25 mL, repeated as needed
- Reversal of neuromuscular blockade: 0.2 mg (0.4 mL) for every 1 mg neostigmine or equivalent dose of physostigmine or pyridostigmine
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION Hyoscyamine Sulfate Oral Drops (Hyoscyamine Sulfate Oral Solution, USP) Dosage may be adjusted according to the conditions and severity of symptoms. Measure dosage very carefully. Adults and pediatric patients 12 years of age and older : 1 to 2 mL every four hours or as needed. Do not exceed 12 mL in 24 hours. Pediatric patients 2 to under 12 years of age : 1/4 to 1 mL every four hours or as needed. Do not exceed 6 mL in 24 hours. Pediatric patients under 2 years of age : The following dosage guide is based upon body weight. The doses may be repeated every four hours or as needed. Body Weight Usual Dose Do Not Exceed In 24 Hours 3.4 kg (7.5 lb.) 4 drops 24 drops 5 kg (11 lb.) 5 drops 30 drops 7 kg (15 lb.) 6 drops 36 drops 10 kg (22 lb.) 8 drops 48 drops Use a dropper having markings of 3, 4, 5 DROPS, and 0.25 mL. The approximate equivalent amount of hyoscyamine sulfate drops (mL) and its equivalent amount of hyoscyamine sulfate (mg) for each marking are as follows: Approximate Equivalent Amount Marking on Dropper Hyoscyamine Sulfate Oral Drops Solution (mL) Hyoscyamine Sulfate (mg) 3 DROPS 0.08 mL 0.01 mg 4 DROPS 0.11 mL 0.01375 mg 5 DROPS 0.14 mL 0.0175 mg 0.25 mL 0.25 mL 0.03125 mg Hyoscyamine Sulfate Elixir Dosage may be adjusted according to the conditions and severity of symptoms. Measure dosage very carefully. Adults and pediatric patients 12 years of age and older : 1 to 2 teaspoonfuls every four hours or as needed. Do not exceed 12 teaspoonfuls in 24 hours. Pediatric patients 2 to under 12 years of age : Please see the following dosage guide is based on body weight. The doses may be repeated every four hours or as needed. Do not exceed 6 teaspoonfuls in 24 hours. Body Weight Usual Dose 10 kg (22 lb.) 1/4 teaspoon (1.25 mL) 20 kg (44 lb.) 1/2 teaspoonful (2.5 mL) 40 kg (88 lb.) 3/4 teaspoonful (3.75 mL) 50 kg (110 lb.) 1 teaspoonful (5 mL) Hyoscyamine Sulfate Tablets, 0.125 mg Hyoscyamine Sulfate Sublingual Tablets, 0.125 mg Hyoscyamine Sulfate Orally Disintegrating Tablets, 0.125 mg Dosage may be adjusted according to the conditions and severity of symptoms. The sublingual tablets may be taken sublingually, orally or chewed. Adults and pediatric patients 12 years of age and older: 1 to 2 tablets every four hours or as needed. Do not exceed 12 tablets in 24 hours.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Hyoscyamine side effects
▾
Most side effects come from the drug’s drying and muscle-relaxing effects.
Common side effects
- Dry mouth
- Blurred vision
- Drowsiness or dizziness
- Constipation
- Difficulty starting urination or urinary retention
- Headache
- Nausea or vomiting
- Decreased sweating
- Drowsiness, dizziness or weakness
- Constipation or bloating
- Fast heartbeat or palpitations
When to get medical help
- Get medical help right away if you have fever or heat stroke signs in hot weather (heat prostration from decreased sweating).
- Call your doctor if you have confusion, hallucinations, memory loss, disorientation or unusual agitation.
- Call your doctor if you cannot urinate.
- Call your doctor if you develop diarrhea, especially with an ileostomy or colostomy, since it can be an early sign of a partial bowel blockage.
- Seek help for a fast or pounding heartbeat, eye pain or hives and other allergic reactions.
Call your doctor for confusion, hallucinations, memory loss, inability to urinate, hives or signs of overheating.
Hyoscyamine warnings and precautions
▾
Overheating: decreased sweating can cause fever and heat stroke in hot environments.
- It can cause drowsiness, dizziness or blurred vision, so be careful driving.
- Psychosis and confusion have been reported in sensitive people, and symptoms usually clear in 12 to 48 hours after stopping.
- Diarrhea can be an early sign of partial bowel blockage, especially with an ileostomy or colostomy.
- Older adults may be more sensitive.
Hyoscyamine interactions
▾
Hyoscyamine can add to the effects of other drugs that block acetylcholine.
- Other antimuscarinics, amantadine, haloperidol, phenothiazines, MAO inhibitors, tricyclic antidepressants and some antihistamines: additive effects.
- Antacids: may reduce absorption, so take hyoscyamine before meals and antacids after.
Interactions listed in the FDA-approved label
From the Hyoscyamine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Other antimuscarinics: Additive adverse effects resulting from cholinergic blockade may occur.
- Amantadine: Additive adverse effects resulting from cholinergic blockade may occur.
- Haloperidol: Additive adverse effects resulting from cholinergic blockade may occur.
- Phenothiazines: Additive adverse effects resulting from cholinergic blockade may occur.
- Monoamine oxidase (MAO) inhibitors: Additive adverse effects resulting from cholinergic blockade may occur.
- Tricyclic antidepressants: Additive adverse effects resulting from cholinergic blockade may occur.
- Some antihistamines: Additive adverse effects resulting from cholinergic blockade may occur.
- Antacids: Antacids may interfere with the absorption of hyoscyamine sulfate. Administer Hyoscyamine Sulfate Orally Disintegrating Tablets before meals, antacids after meals.
Read the label’s full interactions text
Drug Interactions Additive adverse effects resulting from cholinergic blockade may occur when hyoscyamine sulfate is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines. Antacids may interfere with the absorption of hyoscyamine sulfate. Administer Hyoscyamine Sulfate Orally Disintegrating Tablets before meals, antacids after meals.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Hyoscyamine
▾
- Do not use with glaucoma.
- Do not use with obstructive uropathy such as bladder neck obstruction from prostate enlargement.
- Do not use with gastrointestinal obstruction, paralytic ileus or intestinal atony in elderly or debilitated patients.
- Do not use with severe ulcerative colitis or toxic megacolon.
- Do not use with myasthenia gravis.
- Do not use with unstable cardiovascular status in acute bleeding.
- Older adults may be more sensitive.
- Hyoscyamine crosses the placenta and only traces appear in breast milk, so ask your doctor.
Hyoscyamine overdose
▾
Overdose can cause headache, nausea, vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, dry mouth, trouble swallowing and CNS stimulation. Treatment includes stomach lavage and physostigmine, along with symptom care such as fever control. Seek emergency help right away.
What Hyoscyamine does in the body
▾
Hyoscyamine blocks acetylcholine in smooth muscle, heart tissue and glands. It slows movement in the gut, lowers stomach acid and reduces secretions in the throat, windpipe and bronchial tubes. At usual doses it does not act on autonomic ganglia.
How your body processes Hyoscyamine
▾
Hyoscyamine is absorbed well by mouth, clears quickly from the blood and spreads through the body. Its half-life is about 2 to 3½ hours. Most of it leaves in the urine unchanged within 12 hours. The extended-release tablet releases the drug over 12 hours, with peak levels around 4 hours and a longer half-life of about 7.5 hours.
How to store Hyoscyamine
▾
Store at controlled room temperature 20-25°C (68-77°F). Dispense in tight, light-resistant containers as defined in USP/NF with a child-resistant closure. KEEP OUT OF REACH OF CHILDREN In case of accidental overdose, call a Poison Control Center immediately.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Hyoscyamine
46 supplements and herbal products have documented interactions with Hyoscyamine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 32
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Hyoscyamine: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Hyoscyamine — the kind of thing our pharmacy team would talk through with you at the counter.
What am I taking this for?
▾
When should I take it?
▾
What side effects should I expect?
▾
Is it okay to use in hot weather?
▾
Can I take it with my other medicines?
▾
Who should not take it?
▾
Is Hyoscyamine available over the counter?
▾
When was Hyoscyamine first available?
▾
Who makes Hyoscyamine?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Hyoscyamine on HelloPharmacist
Hyoscyamine forms and strengths (how it comes)
Hyoscyamine is available in 7 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Hyoscyamine inactive ingredients by manufacturer.
Tablet
How this form is used
- Digenyx is used as add-on therapy for peptic ulcer, irritable bowel syndrome and neurogenic bladder.
- Levsin tablets are also used for infant colic (elixir and drops) and acute rhinitis.
- Digenyx is taken by mouth 30 to 60 minutes before meals and at bedtime.
- Hyoscyamine Sulfate TAB is taken by mouth, with or without water, before meals and at bedtime.
Oral solution
How this form is used
- Hyosyne oral drops are used as add-on therapy for peptic ulcer and irritable bowel syndrome.
- Hyosyne elixir and drops are also used for infant colic.
- Hyosyne oral drops should be measured very carefully with the supplied dropper.
- Hyosyne dosing for children under 2 years is based on body weight.
Sublingual tablet
How this form is used
- Hyoscyamine Sulfate Sublingual Tablets are used as add-on therapy for peptic ulcer and irritable bowel syndrome.
- Hyoscyamine Sulfate Sublingual Tablets are used with narcotics for biliary and renal colic.
- Hyoscyamine Sulfate SL is taken under the tongue, with or without water.
- Hyoscyamine Sulfate SL is taken before meals and at bedtime.
Orally disintegrating tablet
How this form is used
- Hyoscyamine Sulfate Orally Disintegrating Tablets are used as add-on therapy for peptic ulcer and irritable bowel syndrome.
- Hyoscyamine Sulfate Orally Disintegrating Tablets are used for parkinsonism symptoms and acute rhinitis.
- Hyoscyamine Sulfate Orally Disintegrating Tablets are placed on the tongue to dissolve, with or without water.
- Hyoscyamine Sulfate ODT is taken before meals and at bedtime, and antacids are taken after meals.
Extended-release tablet
How this form is used
- Levbid is used as add-on therapy for peptic ulcer and irritable bowel syndrome.
- Levbid is also used for parkinsonism symptoms and acute rhinitis.
- Hyoscyamine Sulfate Extended-Release Tablets release the drug over 12 hours, and tablets may not fully break down.
Injection
How this form is used
- Hyoscyamine Sulfate Injection is used as add-on therapy for peptic ulcer and for spasm in acute episodes.
- Hyoscyamine Sulfate Injection can reduce gut motility for procedures like endoscopy.
- Hyoscyamine Sulfate Injection is also used before anesthesia and for pancreatitis pain, and as an antidote for anticholinesterase poisoning.
- Hyoscyamine Sulfate Injection is given by a healthcare professional and is checked for particles and discoloration before use.
Chewable tablet
How this form is used
- NuLev is used as add-on therapy for peptic ulcer and irritable bowel syndrome.
- NuLev is used with narcotics for biliary and renal colic.
- NuLev Chewable Melt may be chewed or placed on the tongue to dissolve.
- NuLev may be taken with or without water.
Hyoscyamine on the U.S. market: products, makers and brands
How Hyoscyamine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
23 companies list 54 Hyoscyamine product records with the FDA, mostly as tablet, oral solution, sublingual tablet; the earliest marketing or approval year on record is 1955. Brand names on the directory include Cystospaz, ED-Spaz, Hyomax and 13 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Hyoscyamine is used (Medicaid data)
A general measure of how commonly Hyoscyamine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Hyoscyamine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Hyoscyamine prescribed? Of the 1,601 medications we measure, Hyoscyamine ranks #432 by Medicaid prescriptions — more than 73% of them.
Utilization by Hyoscyamine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
hyoscyamine sulfate 0.125 MG Sublingual Tablet Most dispensed
Summed across the 6 of 49 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1046982
hyoscyamine sulfate 0.125 MG Oral Tablet
Summed across the 5 of 43 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1047905
hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet
Summed across the 4 of 19 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1046985
12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
Summed across the 3 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1046770
hyoscyamine sulfate 0.025 MG/ML Oral Solution
Summed across the 2 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1047881
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Hyoscyamine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 20 of 140 listed Hyoscyamine NDCs with Medicaid activity.
Compare Hyoscyamine products
A representative set of FDA-listed product records for Hyoscyamine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Chewable tablet | ||||
| 0.125 mg | Oral | Viatris Specialty LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Extended-release tablet | ||||
| 0.375 mg | Oral | ANI Pharmaceuticals, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.375 mg | Oral | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.375 mg | Oral | Laser Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.375 mg | Oral | Mylan Pharmaceuticals Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.375 mg | Oral | Patrin Pharma, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.375 mg | Oral | Viatris Specialty LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Injection | ||||
| 0.5 mg/mL | Subcutaneous | BPI Labs LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Orally disintegrating tablet | ||||
| 0.125 mg | Oral | Acella Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | ANI Pharmaceuticals, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Granulation Technology, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Patrin Pharma, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | PD-Rx Pharmaceuticals, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Viatris Specialty LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Westminster Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Oral solution | ||||
| 0.125 mg/5 mL | Oral | Atlantic Biologicals Corp. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg/5 mL | Oral | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg/mL | Oral | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg/5 mL | Oral | Lannett Company, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg/mL | Oral | Lannett Company, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Sublingual tablet | ||||
| 0.125 mg | Sublingual | Acella Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | ANI Pharmaceuticals, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Bryant Ranch Prepack | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral, Sublingual | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Direct_Rx | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Granulation Technology, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Larken Laboratories, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | NCS HealthCare of KY, LLC dba Vangard Labs | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Patrin Pharma, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Sublingual | Redpharm Drug | UNAPPROVED DRUG OTHER | View NDC → |
| 💊Tablet | ||||
| 0.125 mg | Oral | Acella Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | ANI Pharmaceuticals, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Bryant Ranch Prepack × 5 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Chartwell RX, LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Granulation Technology, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Larken Laboratories, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Northwind Health Company, LLC × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Patrin Pharma, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Proficient Rx LP | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | PureTek Corporation | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | QPharma, Inc. | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Remedyrepack Inc. × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Viatris Specialty LLC | UNAPPROVED DRUG OTHER | View NDC → |
| 0.125 mg | Oral | Westminster Pharmaceuticals, LLC × 2 listings | UNAPPROVED DRUG OTHER | View NDC → |
Showing 54 of 54 products — FDA National Drug Code Directory. See every product, package size and price: browse all 54 Hyoscyamine NDCs →
Hyoscyamine side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Hyoscyamine — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Hyoscyamine are nausea, diarrhoea, pain; about 62% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Hyoscyamine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Hyoscyamine FDA approval history
How Hyoscyamine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Hyoscyamine recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Hyoscyamine recalls since July 2021.
✅No Hyoscyamine recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 153970 6 dose forms · 8 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 370665In current FDA listingsClinical drug / strength (SCD) sulfate 0.125 MGRxCUI 1046985 -
Dose form (SCDF) Extended Release Oral Tablet RxCUI 378214In current FDA listingsClinical drug / strength (SCD) Biphasic 12 HR hyoscyamine sulfate 0.375 MGRxCUI 180788612 HR hyoscyamine sulfate 0.375 MGRxCUI 1046770 -
Dose form (SCDF) Injection RxCUI 1790322In current FDA listingsClinical drug / strength (SCD) 1 ML hyoscyamine sulfate 0.5 MG/MLRxCUI 1047916 -
Dose form (SCDF) Oral Solution RxCUI 372445In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 370666In current FDA listingsClinical drug / strength (SCD) sulfate 0.125 MGRxCUI 1047905 -
Dose form (SCDF) Sublingual Tablet RxCUI 370667In current FDA listingsClinical drug / strength (SCD) sulfate 0.125 MGRxCUI 1046982
Look up RxCUI 153970 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Hyoscyamine supply and shortage status
Whether Hyoscyamine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Hyoscyamine brand names
Hyoscyamine is sold under 16 brand names in the FDA directory — Cystospaz, ED-Spaz, Hyomax, Hyophen and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Hyoscyamine: manufacturers and labelers
23 companies list Hyoscyamine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Chartwell RX, LLC, ANI Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Hyoscyamine drug class (RxNorm)
Hyoscyamine belongs to the Belladonna alkaloids, tertiary amines class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Hyoscyamine page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Wallace Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →